Crescent Biopharma (CBIO) Price to Book Value: 2.276

Crescent Biopharma, Inc. (CBIO)

13.06 +0.70 (+5.66%) USD | NASDAQ | Oct 20, 16:00

13.06 0.00 (0.00%) After-Hours: 20:00

Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2014. Start Trial.

Date	Value
October 19, 2026	2.154
October 16, 2026	2.064
October 15, 2026	2.175
October 14, 2026	2.192
October 13, 2026	2.25
October 12, 2026	2.520
October 09, 2026	2.599
October 08, 2026	2.461
October 07, 2026	2.351
October 06, 2026	2.365
October 05, 2026	2.430
October 02, 2026	2.496
October 01, 2026	2.485
September 30, 2026	2.543
September 29, 2026	2.572
September 28, 2026	2.532
September 25, 2026	2.438
September 24, 2026	2.482
September 23, 2026	2.473
September 22, 2026	2.865
September 21, 2026	2.832
September 18, 2026	2.944
September 17, 2026	2.923
September 16, 2026	2.994
September 15, 2026	3.277

Date	Value
September 14, 2026	3.43
September 11, 2026	3.383
September 10, 2026	3.392
September 09, 2026	3.484
September 08, 2026	3.566
September 04, 2026	3.639
September 03, 2026	3.555
September 02, 2026	3.231
September 01, 2026	3.125
August 31, 2026	2.893
August 28, 2026	3.094
August 27, 2026	3.095
August 26, 2026	3.141
August 25, 2026	2.963
August 24, 2026	2.958
August 21, 2026	2.989
August 20, 2026	2.829
August 19, 2026	3.019
August 18, 2026	2.909
August 17, 2026	3.046
August 14, 2026	2.987
August 13, 2026	2.898
August 12, 2026	2.864
August 11, 2026	2.909
August 10, 2026	3.020

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks